Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways

Current Opinion in Pharmacology

Volumn 3, Issue 4, 2003, Pages 404-411

  Clark, Andrew R ^a   Lasa, Marina ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PREDNISOLONE; RU 24858; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CUSHING SYNDROME; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFLAMMATORY DISEASE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION TERMINATION;

ANIMALS; APOPTOSIS; CELL DIVISION; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0041802817     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(03)00073-0     Document Type: Review

References (83)

1. Johnson G.L. Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911-1912
2. Clark AR, Dean JL, Saklatvala J: Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 2003, in press.
3. Rincon M. Flavell R.A. Davis R.A. The JNK and p38 MAP kinase signaling pathways in T cell-mediated immune responses Free Radic Biol Med 28 2000 1328-1337
4. Ip Y.T. Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development Curr Opin Cell Biol 10 1998 205-219
5. Ono K. Han J. The p38 signal transduction pathway: activation and function Cell Signal 12 2000 1-13
6. Herlaar E. Brown Z. p38 MAPK signalling cascades in inflammatory disease Mol Med Today 5 1999 439-447
7. Chen C.Y. Del Gatto-Konczak F. Wu Z. Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway Science 280 1998 1945-1949
8. Ming X.F. Kaiser M. Moroni C. c-Jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells EMBO J 17 1998 6039-6048
9. Swantek J.L. Cobb M.H. Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK Mol Cell Biol 17 1997 6274-6282
10. Neininger A. Kontoyiannis D. Kotlyarov A. Winzen R. Eckert R. Volk H.D. Holtmann H. Kollias G. Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels J Biol Chem 277 2002 3065-3068
11. Vermeulen L. De Wilde G. Damme P.V. Vanden Berghe W. Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1) EMBO J 22 2003 1313-1324
12. Saccani S. Pantano S. Natoli G. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment Nat Immunol 3 2002 69-75.
13. Caamano J. Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions Clin Microbiol Rev 15 2002 414-429
14. Thomson S. Clayton A.L. Hazzalin C.A. Rose S. Barratt M.J. Mahadevan L.C. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase EMBO J 18 1999 4779-4793
15. Dumitru C.D. Ceci J.D. Tsatsanis C. Kontoyiannis D. Stamatakis K. Lin J. Patriotis C. Jenkins N.A. Copeland N.G. Kollias G. et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway Cell 103 2000 1071-1083
16. Esnault S. Malter J.S. Granulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectin J Immunol 166 2001 4658-4663
17. Rutault K. Hazzalin C.A. Mahadevan L.C. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts J Biol Chem 276 2001 6666-6674
18. Hogquist K.A. Signal strength in thymic selection and lineage commitment Curr Opin Immunol 13 2001 225-231
19. Adachi S. Iwata M. Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes Cell Immunol 215 2002 45-53
20. Kassel O. Cato A.C. Mast cells as targets for glucocorticoids in the treatment of allergic disorders Ernst Schering Res Found Workshop 40 2002 153-176
21. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 2000 603-613
22. Groner B. Shemanko C. Cooperation of nuclear transcription factors regulated by steroid and peptide hormones Ernst Schering Res Found Workshop 40 2002 213-231
23. D'Adamio F. Zollo O. Moraca R. Ayroldi E. Bruscoli S. Bartoli A. Cannarile L. Migliorati G. Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death Immunity 7 1997 803-812
24. Berrebi D. Bruscoli S. Cohen N. Foussat A. Migliorati G. Bouchet-Delbos L. Maillot M.C. Portier A. Couderc J. Galanaud P. et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10 Blood 101 2003 729-738
25. Cannarile L. Zollo O. D'Adamio F. Ayroldi E. Marchetti C. Tabilio A. Bruscoli S. Riccardi C. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene Cell Death Differ 8 2001 201-203
26. Galon J. Franchimont D. Hiroi N. Frey G. Boettner A. Ehrhart-Bornstein M. O'Shea J.J. Chrousos G.P. Bornstein S.R. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells FASEB J 16 2002 61-71
27. Tonko M. Ausserlechner M.J. Bernhard D. Helmberg A. Kofler R. Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis FASEB J 15 2001 693-699
28. Mittelstadt P.R. Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ J Biol Chem 276 2001 29603-29610
29. Ayroldi E. Migliorati G. Bruscoli S. Marchetti C. Zollo O. Cannarile L. D'Adamio F. Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB Blood 98 2001 743-753
30. Ayroldi E. Zollo O. Macchiarulo A. Di Marco B. Marchetti C. Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1 Mol Cell Biol 22 2002 7929-7941
31. Widen C. Zilliacus J. Gustafsson J.A. Wikstrom A.C. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways J Biol Chem 275 2000 39296-39301
32. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling Curr Opin Cell Biol 12 2000 186-192
33. Tamura S. Hanada M. Ohnishi M. Katsura K. Sasaki M. Kobayashi T. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases Eur J Biochem 269 2002 1060-1066
34. Lasa M. Abraham S.M. Boucheron C. Saklatvala J. Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38 Mol Cell Biol 22 2002 7802-7811
35. Imasato A. Desbois-Mouthon C. Han J. Kai H. Cato A.C. Akira S. Li J.D. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2 J Biol Chem 277 2002 47444-47450
36. Kassel O. Sancono A. Kratzschmar J. Kreft B. Stassen M. Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 EMBO J 20 2001 7108-7116
37. Chen P. Li J. Barnes J. Kokkonen G.C. Lee J.C. Liu Y. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages J Immunol 169 2002 6408-6416
38. Engelbrecht Y. de Wet H. Horsch K. Langeveldt C.R. Hough F.S. Hulley P.A. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines Endocrinology 144 2003 412-422
39. Franklin C.C. Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells J Biol Chem 272 1997 16917-16923
40. Refojo D. Liberman A.C. Holsboer F. Arzt E. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids Immunol Cell Biol 79 2001 385-394
41. De Bosscher K. Vanden Berghe W. Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors J Neuroimmunol 109 2000 16-22
42. Gottlicher M. Heck S. Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action J Mol Med 76 1998 480-489
43. De Bosscher K. Schmitz M.L. Vanden Berghe W. Plaisance S. Fiers W. Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation Proc Natl Acad Sci USA 94 1997 13504-13509
44. Nissen R.M. Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain Genes Dev 14 2000 2314-2329
45. Adcock I.M. Nasuhara Y. Stevens D.A. Barnes P.J. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement Br J Pharmacol 127 1999 1003-1011
46. Rogatsky I. Zarember K.A. Yamamoto K.R. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones EMBO J 20 2001 6071-6083
47. Jonat C. Rahmsdorf H.J. Park K.K. Cato A.C. Gebel S. Ponta H. Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Cell 62 1990 1189-1204
48. Heck S. Kullmann M. Gast A. Ponta H. Rahmsdorf H.J. Herrlich P. Cato A.C. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1 EMBO J 13 1994 4087-4095
49. Heck S. Bender K. Kullmann M. Gottlicher M. Herrlich P. Cato A.C. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor EMBO J 16 1997 4698-4707
50. Helmberg A. Auphan N. Caelles C. Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor EMBO J 14 1995 452-460
51. Liden J. Delaunay F. Rafter I. Gustafsson J. Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation J Biol Chem 272 1997 21467-21472
52. Cole T.J. Blendy J.A. Monaghan A.P. Krieglstein K. Schmid W. Aguzzi A. Fantuzzi G. Hummler E. Unsicker K. Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation Genes Dev 9 1995 1608-1621
53. Reichardt H.M. Kaestner K.H. Tuckermann J. Kretz O. Wessely O. Bock R. Gass P. Schmid W. Herrlich P. Angel P. et al. DNA binding of the glucocorticoid receptor is not essential for survival Cell 93 1998 531-541
54. Tuckermann J.P. Reichardt H.M. Arribas R. Richter K.H. Schutz G. Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin J Cell Biol 147 1999 1365-1370
55. Reichardt H.M. Tuckermann J.P. Gottlicher M. Vujic M. Weih F. Angel P. Herrlich P. Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor EMBO J 20 2001 7168-7173
56. Belvisi M.G. Wicks S.L. Battram C.H. Bottoms S.E. Redford J.E. Woodman P. Brown T.J. Webber S.E. Foster M.L. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity J Immunol 166 2001 1975-1982
57. Vayssiere B.M. Dupont S. Choquart A. Petit F. Garcia T. Marchandeau C. Gronemeyer H. Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo Mol Endocrinol 11 1997 1245-1255
58. Vanden Berghe W. Francesconi E. De Bosscher K. Resche-Rigon M. Haegeman G. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism Mol Pharmacol 56 1999 797-806
59. Caelles C. Gonzalez-Sancho J.M. Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway Genes Dev 11 1997 3351-3364
60. Gonzalez M.V. Jimenez B. Berciano M.T. Gonzalez-Sancho J.M. Caelles C. Lafarga M. Munoz A. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution J Cell Biol 150 2000 1199-1208
61. Lasa M. Brook M. Saklatvala J. Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38 Mol Cell Biol 21 2001 771-780
62. Newton R. Seybold J. Kuitert L.M. Bergmann M. Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA J Biol Chem 273 1998 32312-32321
63. Xia Z. Dickens M. Raingeaud J. Davis R.J. Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326-1331
64. Amsterdam A. Sasson R. The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis Mol Cell Endocrinol 189 2002 1-9
65. Greenstein S. Ghias K. Krett N.L. Rosen S.T. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies Clin Cancer Res 8 2002 1681-1694
66. Distelhorst C.W. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis Cell Death Differ 9 2002 6-19
67. Riccardi C. Bruscoli S. Migliorati G. Molecular mechanisms of immunomodulatory activity of glucocorticoids Pharmacol Res 45 2002 361-368
68. Riccardi C. Bruscoli S. Ayroldi E. Agostini M. Migliorati G. GILZ, a glucocorticoid hormone induced gene, modulates T lymphocytes activation and death through interaction with NF-kB Adv Exp Med Biol 495 2001 31-39
69. Jamieson C.A. Yamamoto K.R. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling Proc Natl Acad Sci USA 97 2000 7319-7324
70. Rogatsky I. Logan S.K. Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase Proc Natl Acad Sci USA 95 1998 2050-2055
71. Irusen E. Matthews J.G. Takahashi A. Barnes P.J. Chung K.F. Adcock I.M. p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma J Allergy Clin Immunol 109 2002 649-657
72. Krstic M.D. Rogatsky I. Yamamoto K.R. Garabedian M.J. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor Mol Cell Biol 17 1997 3947-3954
73. Xaus J. Comalada M. Valledor A.F. Cardo M. Herrero C. Soler C. Lloberas J. Celada A. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis Immunobiology 204 2001 543-550
74. Karahashi H. Nagata K. Ishii K. Amano F. A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1 Biochim Biophys Acta 1502 2000 207-223
75. Park J.M. Greten F.R. Li Z.W. Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition Science 297 2002 2048-2051
76. Hulley P.A. Conradie M.M. Langeveldt C.R. Hough F.S. Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate Bone 31 2002 220-229
77. Davis R.J. Signal transduction by the c-Jun N-terminal kinase Biochem Soc Symp 64 1999 1-12
78. Sanchez-Perez I. Martinez-Gomariz M. Williams D. Keyse S.M. Perona R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin Oncogene 19 2000 5142-5152
79. Franklin C.C. Srikanth S. Kraft A.S. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis Proc Natl Acad Sci USA 95 1998 3014-3019
80. Xu Q. Konta T. Furusu A. Nakayama K. Lucio-Cazana J. Fine L.G.Kitamura M.Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect J Biol Chem 277 2002 41693-41700
81. Srikanth S. Franklin C.C. Duke R.C. Kraft R.S. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis Mol Cell Biochem 199 1999 169-178
82. Guo Y.L. Kang B. Williamson J.R. Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells J Biol Chem 273 1998 10362-10366
83. Dorfman K. Carrasco D. Gruda M. Ryan C. Lira S.A. Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts Oncogene 13 1996 925-931